DK4153599T3 - Fremgangsmåde til at fremstille alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridin-carboxylat - Google Patents
Fremgangsmåde til at fremstille alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridin-carboxylat Download PDFInfo
- Publication number
- DK4153599T3 DK4153599T3 DK21726114.8T DK21726114T DK4153599T3 DK 4153599 T3 DK4153599 T3 DK 4153599T3 DK 21726114 T DK21726114 T DK 21726114T DK 4153599 T3 DK4153599 T3 DK 4153599T3
- Authority
- DK
- Denmark
- Prior art keywords
- oxadiazolo
- amino
- methyl
- procedure
- pyridine carboxylate
- Prior art date
Links
- -1 7-AMINO-5-METHYL-[1,2,5]OXADIAZOLO[3,4-B]PYRIDINE CARBOXYLATE Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20176112 | 2020-05-22 | ||
| PCT/EP2021/063088 WO2021233882A1 (en) | 2020-05-22 | 2021-05-18 | Process for manufacturing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine-carboxylate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4153599T3 true DK4153599T3 (da) | 2024-06-17 |
Family
ID=70804542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK21726114.8T DK4153599T3 (da) | 2020-05-22 | 2021-05-18 | Fremgangsmåde til at fremstille alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridin-carboxylat |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11518771B2 (da) |
| EP (1) | EP4153599B1 (da) |
| JP (1) | JP7702968B2 (da) |
| CN (1) | CN115884974B (da) |
| DK (1) | DK4153599T3 (da) |
| ES (1) | ES2984466T3 (da) |
| HU (1) | HUE066997T2 (da) |
| PL (1) | PL4153599T3 (da) |
| TW (1) | TW202208377A (da) |
| WO (1) | WO2021233882A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115916789B (zh) * | 2020-05-22 | 2025-06-27 | 勃林格殷格翰国际有限公司 | 制备烷基7-氨基-5-甲基-[1,2,5]噁二唑并[3,4-b]吡啶羧酸酯的连续方法 |
| CN118652261B (zh) * | 2024-05-29 | 2025-02-07 | 南京理工大学 | 一种耐热荧光活性含能化合物及其合成方法 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004082383A1 (en) | 2003-03-17 | 2004-09-30 | Basf Aktiengesellschaft | Use of triazolopyrimidines for combating nematode diseases of plants |
| CA2536253A1 (en) * | 2003-08-20 | 2005-03-03 | Vertex Pharmaceuticals Incorporated | Aminofurazan compounds useful as protein kinase inhibitors |
| US20090253673A1 (en) | 2006-07-12 | 2009-10-08 | Min Ge | Substituted Pyrazoles as Ghrelin Receptor Antagonists |
| CA2677932A1 (en) | 2007-02-15 | 2008-08-21 | Indiana University Research And Technology Corporation | Glucagon/glp-1 receptor co-agonists |
| CN101720323A (zh) | 2007-04-11 | 2010-06-02 | 三井有限公司 | 具有抗癌活性的化合物 |
| EP2152672A1 (en) | 2007-05-24 | 2010-02-17 | Bayer Schering Pharma Aktiengesellschaft | Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors |
| EP2158214B1 (en) | 2007-06-15 | 2011-08-17 | Zealand Pharma A/S | Glucagon analogues |
| FR2934058B1 (fr) | 2008-07-15 | 2010-09-24 | Centre Nat Rech Scient | Dispositif de projection interferometrique a trois ouvertures pour produire une tache constituee de structures fines |
| FR2933989B1 (fr) | 2008-07-16 | 2013-03-08 | Commissariat Energie Atomique | Procede de purification de microorganismes presents dans des echantillons liquides |
| FR2933975B1 (fr) | 2008-07-17 | 2011-02-18 | Servier Lab | Nouveau procede de preparation de benzocyclobutenes fonctionnalises,et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable. |
| ES2477880T3 (es) | 2008-12-15 | 2014-07-18 | Zealand Pharma A/S | Análogos del glucagón |
| ES2405054T3 (es) * | 2009-01-23 | 2013-05-30 | Bristol-Myers Squibb Company | Derivados de pirazol-1,2,4-oxadiazol como agonistas de esfingosina-1-fosfato |
| AU2010272944B2 (en) | 2009-07-13 | 2015-11-19 | Zealand Pharma A/S | Acylated glucagon analogues |
| US20110078154A1 (en) | 2009-09-28 | 2011-03-31 | Accenture Global Services Gmbh | Recruitment screening tool |
| UY33462A (es) | 2010-06-23 | 2012-01-31 | Zealand Pharma As | Analogos de glucagon |
| US9169310B2 (en) | 2010-06-24 | 2015-10-27 | Zealand Pharma A/S | Glucagon analogues |
| IN2014CN04401A (da) | 2011-12-23 | 2015-09-04 | Zealand Pharma As | |
| US9238639B2 (en) | 2012-02-24 | 2016-01-19 | Takeda Pharmaceutical Company Limited | Aromatic ring compound |
| EP2863910B1 (en) | 2012-06-20 | 2020-03-11 | University Of Virginia Patent Foundation | Compositions and methods for regulating glucose homeostasis and insulin action |
| TWI608013B (zh) | 2012-09-17 | 2017-12-11 | 西蘭製藥公司 | 升糖素類似物 |
| UA118034C2 (uk) | 2013-11-14 | 2018-11-12 | Елі Ліллі Енд Компані | Заміщений піперидилетилпіримідин як інгібітор грелін-o-ацилтрансферази |
| WO2016007634A1 (en) * | 2014-07-08 | 2016-01-14 | Dow Agrosciences Llc | Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids |
| EP3193939A4 (en) | 2014-09-17 | 2018-10-24 | The Regents of The University of California | Small lipopeptidomimetic inhibitors of ghrelin o-acyl transferase |
| EP3230304B1 (en) | 2014-12-11 | 2020-01-01 | Centrient Pharmaceuticals Netherlands B.V. | Method for acylating a cyclic peptide |
| WO2016123275A1 (en) | 2015-01-30 | 2016-08-04 | Boehringer Ingelheim International Gmbh | Aldosterone synthase inhibitors |
| AR104672A1 (es) | 2015-04-15 | 2017-08-09 | Lilly Co Eli | Inhibidores de grelina o-aciltransferasa |
| AR104673A1 (es) | 2015-04-15 | 2017-08-09 | Lilly Co Eli | Inhibidores de grelina o-aciltransferasa |
| DK3364993T3 (da) | 2015-10-22 | 2023-01-09 | Cavion Inc | Fremgangsmåder til behandling af angelman syndrom |
| SG11201811804QA (en) | 2016-08-05 | 2019-01-30 | Boehringer Ingelheim Int | Oxadiazolopyridine derivates for use as ghrelin o-acyl transferase (goat) inhibitors |
| EP3504185B1 (en) | 2016-08-29 | 2021-11-24 | Merck Sharp & Dohme Corp. | Novel substituted n'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (ido) inhibitors |
| WO2019149659A1 (en) * | 2018-02-02 | 2019-08-08 | Boehringer Ingelheim International Gmbh | Heterocyclyl-substituted oxadiazolopyridine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors |
| EP3746449B1 (en) * | 2018-02-02 | 2022-03-30 | Boehringer Ingelheim International GmbH | Pyrazole- and indazole-substituted oxadiazolopyridine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors |
| AU2019215707A1 (en) | 2018-02-02 | 2020-07-09 | Boehringer Ingelheim International Gmbh | Benzyl-, (pyridin-3-yl)methyl- or (pyridin-4-yl)methyl-substituted oxadiazolopyridine derivatives as ghrelin O-acyl transferase (GOAT) inhibitors |
| MX2020007994A (es) | 2018-02-02 | 2020-09-09 | Boehringer Ingelheim Int | Derivados de triazolopirimidina para usar como inhibidores de ghrelin o-aciltransferasa (goat). |
-
2021
- 2021-05-18 WO PCT/EP2021/063088 patent/WO2021233882A1/en not_active Ceased
- 2021-05-18 ES ES21726114T patent/ES2984466T3/es active Active
- 2021-05-18 PL PL21726114.8T patent/PL4153599T3/pl unknown
- 2021-05-18 HU HUE21726114A patent/HUE066997T2/hu unknown
- 2021-05-18 EP EP21726114.8A patent/EP4153599B1/en active Active
- 2021-05-18 CN CN202180037451.0A patent/CN115884974B/zh active Active
- 2021-05-18 DK DK21726114.8T patent/DK4153599T3/da active
- 2021-05-18 JP JP2022570155A patent/JP7702968B2/ja active Active
- 2021-05-21 TW TW110118393A patent/TW202208377A/zh unknown
- 2021-05-21 US US17/326,382 patent/US11518771B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL4153599T3 (pl) | 2024-07-15 |
| WO2021233882A1 (en) | 2021-11-25 |
| ES2984466T3 (es) | 2024-10-29 |
| HUE066997T2 (hu) | 2024-09-28 |
| CN115884974B (zh) | 2024-09-17 |
| JP2023526351A (ja) | 2023-06-21 |
| CN115884974A (zh) | 2023-03-31 |
| US20210363156A1 (en) | 2021-11-25 |
| US11518771B2 (en) | 2022-12-06 |
| JP7702968B2 (ja) | 2025-07-04 |
| EP4153599A1 (en) | 2023-03-29 |
| EP4153599B1 (en) | 2024-03-13 |
| TW202208377A (zh) | 2022-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA54755A (fr) | Dérivés d'imidazo[1,2-a]pyridinyle servant d'inhibiteurs d'irak4 | |
| CY1124582T1 (el) | Μεθοδος παραγωγης ενωσεων που εχουν δρασης αναστολης ιντεγκρασης hiv | |
| LT3790877T (lt) | Tetrahidro-imidazo[4,5-c]piridino dariniai kaip pd-l1 imunomoduliatoriai | |
| DK3959211T3 (da) | 4h-pyrrol[3,2-c]pyridin-4-on-forbindelser | |
| LT3523301T (lt) | Pakeistieji pirazolo[1,5-a]piridino junginiai kaip ret kinazės slopikliai | |
| LT3555097T (lt) | Imidazo[4,5-d]pirolo[2,3-b]piridino junginiai kaip janus kinazės inhibitoriai | |
| IL289877A (en) | History of imidazopyridines and their use in cancer treatment | |
| IL285315A (en) | Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as tlr7 agonist | |
| PH12017501340A1 (en) | 4h-pyrrolo[3,2-c]pyridin-4-one derivatives | |
| IL312020A (en) | Imidazo[1,2-a]pyridine derivatives | |
| MY165215A (en) | Pyridone derivatives | |
| AU2012342891A8 (en) | 3-Cyanoaryl-1H-pyrrolo[2.3-b]pyridine derivatives | |
| CR20130041A (es) | ISOXAZOLO[5,4-b]PIRIDINAS HERBICIDAS | |
| WO2015142903A3 (en) | Method of controlling lactate production with piperdine-dione derivatives | |
| EP3102036A4 (en) | 3-substituted carbonyl-naphtho[2,3-b]furane derivative or pharmaceutically acceptable salt thereof | |
| DK4153599T3 (da) | Fremgangsmåde til at fremstille alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridin-carboxylat | |
| MX2017007574A (es) | Composicion. | |
| EP4090659C0 (en) | 3-BENZOYL-1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS MKK4 INHIBITORS FOR THE TREATMENT OF LIVER DISEASES | |
| IL264780B (en) | A method for producing 2-(3,6-dihalopyridin-2-yl)-3h-imidazolo[4,5-c]pyridine derivatives and similar compounds by reacting a 3h-imidazolo[4,5-c]pyridine derivative with a base Organometallic zinc-amine | |
| MX2017007572A (es) | Composicion acuosa. | |
| MX354136B (es) | Metodos para preparar 3-sustituido. 6-trifluorometil piridinas y metodos para la utilizacion de 6-triclorometil piridinas halogenadas. | |
| DK3194389T3 (da) | Ssao inhibitorer afledt af imidazo[4,5-c]pyridin | |
| HUE060319T2 (hu) | Imidazo[1,2-b]piridazin származékok TRK inhibitorként | |
| EP3712139A4 (en) | ANTIHBV TETRAHYDROISOXAZOLO [4,3-C] PYRIDINE COMPOUNDS | |
| DK4153600T3 (da) | Kontinuerlig fremgangsmåde til fremstilling af alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridin-carboxylat |